Conference Press Release » Biotechnology

International Supercomputing Conference ISC’10, May 31 – June 3, 2010, Hamburg

admin — Fri, 16 Oct 2009 14:47:32 +0000

ISC’10, International Supercomputing Conference, will take place on May 31 – June 3, 2010 in Hamburg, Germany. With about 2,000 attendees and more than 140 exhibitors from over 45 countries expected to attend, ISC’10 is sure to be one of the world’s biggest and best high performance computing events.

According to a market report “Worldwide Defense High Performance Computing (HPC) Market Forecast 2010-2015” recently released by Market Research Media, the global defense high performance computing market is projected to increase from $2.6 billion in 2010 to $3.3 billion in 2015. The estimate for worldwide cumulative market 2010 – 2015 is $18 billion, for a compound annual growth rate (CAGR) of 4.7% in the 6-year period.

Conference Topics
The four-day conference will highlight numerous cutting-edge presentations broken up into various sessions focusing on innovations and applications of supercomputing.

The areas of emphasis amongst others will be:

High Performance Computational Life Sciences – The Challenge for HPC Systems
Evolving New HPC Markets: China, Middle East and Russia
Fault Tolerance for Manycore Systems
HPC: Future Technology Building Blocks
High Performance Computing & Networking
Storage/Flash Technology in HPC
Focusing Linpack: The TOP500 Yardstick
Innovative Applications (Cryptography, Gaming, Aerospace, Finance, Defense)
Presentation of the 35th TOP500 List of the World’s Fastest Supercomputers
Panel on Exascale Computing

Scientific, BoF, Hot Seat and Poster Sessions, Award Ceremonies, Exhibitor Forums and numerous networking opportunities and social events will complete the 2010 conference program.

DETECTION TECHNOLOGIES 2009 - November 5-6, 2009 - Washington, DC

admin — Wed, 12 Aug 2009 08:25:05 +0000

The 15th Detection Technologies conference - Detection & Identification of Toxins & Pathogens - will be held in Washington, DC from November 5-6, 2009.

Detection Technologies is an event for experts in detection and identification of biological and chemical threats. The eventl explore the latest R&D developments as well as ready-to-market systems for major biothreat detection, identification, and analysis both in the field and at the point-of-care. The opening keynote address from the U.S. Department of Homeland Security will discuss the next generation biological detection program.

Event highlights:

New generation of sensors and detectors
Rapid, reliable, continuous, automated chemical and biodetection
Chemical and biological agents sample preparation
PCR and non-PCR based detection techniques
Reagent and reagentless detection systems
Point-of-care threat detection
Field-ready devices: compatibility/reliability/scalability

DermaVir Nanomedicine: The Next Generation DNA Vaccine

admin — Thu, 18 Jun 2009 17:34:20 +0000

Dr. Julianna Lisziewicz, Chief Executive Officer of the Genetic Immunity, will be presenting “DermaVir Nanomedicine: The Next Generation DNA Vaccine” at Phacilitate’s 8th annual European Vaccine Forum, to be held from June 22-24, 2009 Barcelona, Spain.

“I look forward to discussing the latest developments on our nanomedicine and dendritic cell targeting delivery system with conference attendees and to learn more about the progress of other companies active in the fields of immune therapy and vaccines. This event, just like the Bio International Convention in Atlanta, will give us many opportunities to look for partnerships and, or to reach for greater exposure of our immunotherapeutics technology,” commented Julianna Lisziewicz, CEO of the Company.

8th annual European Vaccine Forum will take place in Barcelona in June 2009. Phacilitate’s 8th annual European Vaccine Forum will run in parallel this year to a new conference — the Active Immunotherapeutics Forum. Dr. Lisziewicz will be attending both conferences.

About Genetic Immunity
Genetic Immunity is a US/Hungarian biopharmaceutical company establishing leadership in Nanomedicines for immune amplification. Nanomedicine, an offshoot of nanotechnology, refers to highly specific medical intervention at the molecular scale for treating disease or repairing damaged tissues. By leveraging its proprietary immune amplification platform technology, the Company aims to address new markets for infectious diseases, cancer and allergies through the discovery, development and commercialization of topically administered nanomedicines. These indications represent a significant unmet medical need and the potential for alternative treatment approaches.

More information:
Vaccine Market
Global Pandemic Influenza Preparedness Market Forecast 2010-2015
The Active Immunotherapeutics Forum, June 22-24 2009, Barcelona

7th annual Basel Computational Biology Conference ‘Molecular Evolution’ June 18-19, 2009

admin — Thu, 18 Jun 2009 16:49:59 +0000

This year, the Basel’s 7th annual [BC]2 Basel Computational Biology Conference “Molecular Evolution” celebrates the 200th birthday of Charles Darwin and the 150th anniversary of the publication of his major work, “On the Origin of the Species”. The conference is organized by the SIB Swiss Institute of Bioinformatics and the Biozentrum of the University of Basel.

The Active Immunotherapeutics Forum, June 22-24 2009, Barcelona

admin — Thu, 18 Jun 2009 16:35:50 +0000

The Active Immunotherapeutics Forum will provide a new and timely annual meeting place for senior level figures driving the development of these technologies into clinically effective, cost-effective products that are acceptable to the regulator. Phacilitate’s The Active Immunotherapeutics Forum will take place in Barcelona in June 2009. Therapeutic vaccines against a variety of disease targets, as well as other immune modulating approaches, will be covered, with the emphasis on how clinical, regulatory and manufacturing challenges are being overcome.

AIDS Vaccine 2009, October 19-22, Paris

admin — Wed, 17 Jun 2009 18:17:24 +0000

The AIDS Vaccine Conference 2009, which will be held at the Marriott Rive Gauche Conference Center on the 19th to the 22nd of October 2009. AIDS Vaccine 2009 will bring together research scientists, clinicians, epidemiologists and public health experts to share knowledge towards the development of an HIV vaccine.